Creatine therapy for Huntington's disease: Clinical and MRS findings in a 1-year pilot study

被引:64
作者
Tabrizi, SJ
Blamire, AM
Manners, DN
Rajagopalan, B
Styles, P
Schapira, AHV
Warner, TT
机构
[1] UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England
[2] Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England
[3] Univ Oxford, Dept Biochem, Magnet Resonance Spect Unit, MRC, Oxford OX1 3QU, England
[4] John Radcliffe Hosp, Oxford OX3 9DU, England
关键词
D O I
10.1212/01.WNL.0000070186.97463.A7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:141 / 142
页数:2
相关论文
共 8 条
[1]   Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease [J].
Ferrante, RJ ;
Andreassen, OA ;
Jenkins, BG ;
Dedeoglu, A ;
Kuemmerle, S ;
Kubilus, JK ;
Kaddurah-Daouk, R ;
Hersch, SM ;
Beal, MF .
JOURNAL OF NEUROSCIENCE, 2000, 20 (12) :4389-4397
[2]   Unified Huntington's disease rating scale: Reliability and consistency [J].
Kieburtz, K ;
Penney, JB ;
Como, P ;
Ranen, N ;
Shoulson, I ;
Feigin, A ;
Abwender, D ;
Greenamyre, JT ;
Higgins, D ;
Marshall, FJ ;
Goldstein, J ;
Steinberg, K ;
Shih, C ;
Richard, I ;
Hickey, C ;
Zimmerman, C ;
Orme, C ;
Claude, K ;
Oakes, D ;
Sax, DS ;
Kim, A ;
Hersch, S ;
Jones, R ;
Auchus, A ;
Olsen, D ;
BisseyBlack, C ;
Rubin, A ;
Schwartz, R ;
Dubinsky, R ;
Mallonee, W ;
Gray, C ;
Godfrey, N ;
Suter, G ;
Shannon, KM ;
Stebbins, GT ;
Jaglin, JA ;
Marder, K ;
Taylor, S ;
Louis, E ;
Moskowitz, C ;
Thorne, D ;
Zubin, N ;
Wexler, N ;
Swenson, MR ;
Paulsen, J ;
Swerdlow, N ;
Albin, R ;
Wernette, C ;
Walker, F ;
Hunt, V .
MOVEMENT DISORDERS, 1996, 11 (02) :136-142
[3]  
Kieburtz K, 2001, NEUROLOGY, V56, pA386
[4]  
Lodi R, 2000, ANN NEUROL, V48, P72
[5]   Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines [J].
Panov, AV ;
Gutekunst, CA ;
Leavitt, BR ;
Hayden, MR ;
Burke, JR ;
Strittmatter, WJ ;
Greenamyre, JT .
NATURE NEUROSCIENCE, 2002, 5 (08) :731-736
[6]  
Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO
[7]  
2-E
[8]  
Verbessem P, 2002, NEUROLOGY, V58, pA334